Search

Your search keyword '"Ma, Seong Kwon"' showing total 473 results
Start Over Author "Ma, Seong Kwon" Search Limiters Full Text Publication Year Range Last 10 years
473 results on '"Ma, Seong Kwon"'

11. Circulating osteoprotegerin levels and cardiovascular outcomes in patients with pre-dialysis chronic kidney disease: results from the KNOW-CKD study.

Author

Suh, Sang Heon, Oh, Tae Ryom, Choi, Hong Sang, Kim, Chang Seong, Bae, Eun Hui, Ma, Seong Kwon, Oh, Kook-Hwan, Lee, Kyu-Beck, Jeong, Jong Cheol, Jung, Ji Yong, and Kim, Soo Wan

Subjects
CHRONIC kidney failure, MAJOR adverse cardiovascular events, OSTEOPROTEGERIN, DISEASE risk factors, TREATMENT effectiveness
Abstract

While the relationship between circulating osteoprotegerin (OPG) and cardiovascular events is well-established in the general population, its association with cardiovascular risks in chronic kidney disease (CKD) patients remains less robust. This study hypothesized that elevated circulating OPG levels might be associated with an increased risk of major adverse cardiac events (MACE) in CKD patients, a total of 2,109 patients with CKD stages 1 through pre-dialysis 5 from the KNOW-CKD cohort were categorized into quartiles based on serum OPG levels. The primary outcome of the study was 3-point MACE, defined as a composite of nonfatal myocardial infarction, nonfatal stroke, or cardiac death. The median follow-up duration was 7.9 years. The cumulative incidence of 3-point MACE significantly varied across serum OPG levels in Kaplan–Meier curve analysis (P < 0.001, log-rank test), with the highest incidence observed in the 4th quartile. Cox regression analysis indicated that, relative to the 1st quartile, the risk of 3-point MACE was significantly higher in the 3rd (adjusted hazard ratio 2.901, 95% confidence interval 1.009 to 8.341) and the 4th quartiles (adjusted hazard ratio 4.347, 95% confidence interval 1.410 to 13.395). In conclusion, elevated circulating OPG levels are associated with adverse cardiovascular outcomes in pre-dialysis CKD patients. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

29. Fatal Hypermagnesemia in Patients Taking Magnesium Hydroxide

Author

Jou, Da Hye, primary, Kim, Su In, additional, Choi, In Hong, additional, Song, Su Hyun, additional, Oh, Tae Ryom, additional, Suh, Sang Heon, additional, Choi, Hong Sang, additional, Kim, Chang Seong, additional, Kim, Soo Wan, additional, Bae, Eun Hui, additional, and Ma, Seong Kwon, additional

Published
2023
Full Text
View/download PDF

38. Effects of Blood Pressure According to Age on End-Stage Renal Disease Development in Patients With Diabetes: A Nationwide Population-Based Cohort Study

Author

Bae, Eun Hui, primary, Lim, Sang Yeob, additional, Kim, Bongseong, additional, Oh, Tae Ryom, additional, Song, Su Hyun, additional, Suh, Sang Heon, additional, Choi, Hong Sang, additional, Yang, Eun Mi, additional, Kim, Chang Seong, additional, Ma, Seong Kwon, additional, Han, Kyung-Do, additional, and Kim, Soo Wan, additional

Published
2022
Full Text
View/download PDF

44. Association Between Left Ventricular Geometry and Renal Outcomes in Patients With Chronic Kidney Disease: Findings From Korean Cohort Study for Outcomes in Patients With Chronic Kidney Disease Study

Author

Suh, Sang Heon, primary, Oh, Tae Ryom, additional, Choi, Hong Sang, additional, Kim, Chang Seong, additional, Bae, Eun Hui, additional, Oh, Kook-Hwan, additional, Lee, Joongyub, additional, Jung, Ji Yong, additional, Lee, Kyu-Beck, additional, Ma, Seong Kwon, additional, and Kim, Soo Wan, additional

Published
2022
Full Text
View/download PDF

46. Association between serum osteoprotegerin level and renal prognosis in nondialysis patients with chronic kidney disease in the Korean Cohort Study for Outcomes in Patients with Chronic Kidney Disease (the KNOW-CKD Study)

Author

Oh, Tae Ryom, primary, Myeong, Chana, additional, Song, Su Hyun, additional, Choi, Hong Sang, additional, Suh, Sang Heon, additional, Kim, Chang Seong, additional, Bae, Eun Hui, additional, Chung, Wookyung, additional, Choi, Kyu Hun, additional, Oh, Kook Hwan, additional, Ma, Seong Kwon, additional, and Kim, Soo Wan, additional

Published
2022
Full Text
View/download PDF

48. Additional file 1 of Inflammation-sensing catalase-mimicking nanozymes alleviate acute kidney injury via reversing local oxidative stress

Author

Choi, Hong Sang, Mathew, Ansuja Pulickal, Uthaman, Saji, Vasukutty, Arathy, Kim, In Jin, Suh, Sang Heon, Kim, Chang Seong, Ma, Seong Kwon, Graham, Sontyana Adonijah, Kim, Soo Wan, Park, In-Kyu, and Bae, Eun Hui

Subjects
endocrine system diseases
Abstract

Additional file 1: Figure S1. (A) Powder sample of prepared dMn3O4 (B) Schematic representation and (C) EDS analysis of dMn3O4. Figure S2. XPS analysis individual peaks in dMn3O4. Figure S3. NMR analysis (A) PTC and (B) PC. Figure S4. Low magnification FE-TEM images of (A) PTC (B) PC-M, PC-M + H2O2, PTC-M and PTC-M + H2O2. Figure S5. EDS elemental mapping of PTC-M. Figure S6. (A) Lyophilized sample of PTC-M (B) TGA analysis. Figure S7. (A) Hydrodynamic diameter and (B) zeta potential of PTC-M and PC-M before and after exposure to H2O2. Figure S8. (A) Hydrodynamic size distribution and (B) zeta potential of empty nanomicelles (PTC and PC) before and after treatment with H2O2. Figure S9. Stability of PTC-M in 10% FBS. Figure S10. Catalase like activity of PTC-M at different concentrations. Figure S11. (A) Disproportionation of H2O2 by PTC-M resulting in bubble formation (B) Dissolved oxygen production by dMn3O4 and PTC-M. Data is shown as mean ± SEM (n = 3 replicates). Statistics were performed by a one-way ANOVA (*P < 0.05, **P < 0.01, *** P < 0.001, and **** P < 0.0001). Figure S12. In vitro cell viability of the empty nanomicelles (PTC, PC) as well as dMn3O4 loaded nanomicelles (PTC-M, PC-M). Figure S13. Cellular uptake and intracellular IR780 release. High magnification images (Scalebar=75µm). Figure S14. (A) Ex-vivo images of organs at different time points post injection form I/R model mice administered with PC-IR780 and IR780 (B) NIRF signal intensity quantification from isolated kidneys of PTC-IR780, PC-IR780 and IR780 administered mice in I/R model at different time points. Figure S15. Ex-vivo images of major organs at different time points post injection form normal C57 mice administered with PTC-IR780. Figure S16. ICP-MS analysis of major organs, feces and urine collected from AKI mice administered with PTC-M at 72 h and 168h. Figure S17. H & E staining of all major organs (liver, lung, spleen, heart, and intestine) collected from the control and PTC-M treated AKI mice (at 72 h), scale bar = 200 μm. Table S1. List of primary and secondary antibodies for immunoblotting. Table S2. List of primer sequences for real-time qPCR. Table S3. List of primary and secondary antibodies for immunohistochemistry.

Published
2022
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results